MOVE OVER BREAST CANCER INC

EIN: 842931340 501(c)(3) Diseases & Disorders

PRINCETON, NJ

Total Revenue
$205,826
Total Expenses
$222,763
Total Assets
$163,055
Net Assets
$145,317
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2019
Legal Domicile
NJ
Principal Officer
Paula Flory
Phone
7326906696
Tax Period
2024-01-01 to 2024-12-31

MOVE OVER BREAST CANCER INC, founded in 2019, is a small nonprofit in the Diseases & Disorders sector that reported $206K in total revenue in fiscal year 2024. Revenue decreased 16% compared to the prior year.

Mission

Breast Cancer Awareness Support for individuals currently diagnosed with disease

Program Service Accomplishments

Program 1
Expenses: $222,763 Revenue: $205,825

Provides free support programs and education to individuals diagnosed with breast cancer.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $193,124
Program Service Revenue $0
Investment Income $0
Other Revenue $12,702
TOTAL REVENUE $205,826

Expense Breakdown

Grants Paid $0
Salaries & Benefits $104,400
Fundraising Expenses $0
Program Expenses $222,763
Other Expenses $118,363
TOTAL EXPENSES $222,763

Year-over-Year Comparison

2024 2023 Change
Revenue $205,826 $245,608 -0.2%
Expenses $222,763 $246,618 -0.1%
Net Income $-16,937 $-1,010 +15.8%
Key Indicators
✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
3
Independent Members
N/A
Employees
N/A
Volunteers
N/A

Governance Policies

✗ Conflict of Interest Policy
✗ Whistleblower Policy
✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School
✗ Operated a Hospital
✗ Provided First Class Travel
✗ Reported Conflict of Interest
✗ Reported Asset Diversion
✗ Excess Benefit Transaction
✗ Made Political Expenditures
✗ Engaged in Lobbying
✗ Operated Donor Advised Fund
✗ Maintained Art Collections
✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
3
$77,300
Total Directors
3
$77,300
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
Paula Flory Vice President 40.00
Officer Director
$77,300 $0 $77,300
Charles Flory President 2.00
Officer Director
$0 $0 $0
Paul Xenis Treasurer 5.00
Officer Director
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2025 No data No data No data No data
2024 $205,826 $222,763 $163,055 $-16,937
2023 $245,608 $246,618 $186,060 $-1,010
2022 $168,767 $202,075 $193,726 $-33,308
2021 $213,932 $69,223 $223,450 $144,709
Explore More Nonprofits
→Top 100 Nonprofits in New Jersey →Largest U.S. Nonprofits →Best Rated Nonprofits →Most Efficient Nonprofits

Compare MOVE OVER BREAST CANCER INC with other nonprofits in New Jersey and across the country.

We Value Your Privacy
We use cookies and similar technologies to analyze site traffic and improve your experience. By clicking "Accept All", you consent to our use of cookies for analytics and measurement.